Clinical Trials Directory

Trials / Unknown

UnknownNCT01765998

The Effect of Probiotics on Exacerbation of Inflammatory Bowel Disease Exacerbation (Crohn's Disease)

The Effect of Probiotics on the Rate of Recovery of Inflammatory Bowel Disease Exacerbation (Crohn's Disease) and Markers of Inflammation

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
The Baruch Padeh Medical Center, Poriya · Other Government
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Inflammatory Bowel Disease (IBD) is an immune mediated chronic intestinal condition. It includes ulcerative colitis (UC) and Crohn's disease(CD). probiotics have been shown to be effective in varried clinical conditions ranging fron infantile diarrhea, necrotizing enterocolitis,helicobacter pylori infections, etc.

Detailed description

This is a prospective study that will enroll 50 patients with Crohn's disease.Each patient will get the study medication for 6 weeks and will be evaluated twice- before enrollment and after 6 weeks of treatment.

Conditions

Interventions

TypeNameDescription
DRUGProbioticClinical evaluation according to the Crohn's activity scale
DRUGPlacebo

Timeline

Start date
2013-02-01
Primary completion
2014-02-01
Completion
2014-02-01
First posted
2013-01-11
Last updated
2013-01-11

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01765998. Inclusion in this directory is not an endorsement.